Symbotic Board Member Maintains Strong Position Despite Small Share Sale

Rhea-AI Filing Summary

Director Merline Saintil of Symbotic has reported a sale of 600 shares of Class A Common Stock at a price of $37 per share on June 20, 2025. The transaction was executed through a pre-planned Rule 10b5-1 trading plan established on February 25, 2025.

Following the transaction, Saintil retains beneficial ownership of 77,413 shares held directly. The sale represents a minor reduction in the director's holdings, suggesting routine portfolio management rather than a significant shift in position.

Key details:

• Transaction was conducted under a Rule 10b5-1 trading plan, demonstrating pre-planned nature of the sale
• Total transaction value: $22,200
• Form 4 filed within required reporting timeline
• No derivative securities transactions reported

Insider Trade Summary

Net Seller: 600 shares ($22,200)

Net Sell 1 txn

Insider Saintil Merline

Role Director

Sold 600 shs ($22K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	600	$37.00	$22K

Holdings After Transaction: Class A Common Stock — 77,413 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saintil Merline

(Last) (First) (Middle)

C/O SYMBOTIC INC., 200 RESEARCH DRIVE

(Street)

WILMINGTON MA 01887

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Symbotic Inc. [ SYM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/20/2025		S(1)		600	D	$37	77,413	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed pursuant to a trading plan entered into by the Reporting Person on February 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Remarks:

	/s/ Corey Dufresne, Attorney-in-Fact for Merline Saintil	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of SYM stock did Director Merline Saintil sell on June 20, 2025?

Director Merline Saintil sold 600 shares of Symbotic Inc. (SYM) Class A Common Stock at a price of $37 per share on June 20, 2025.

How many shares of SYM does Merline Saintil own after the June 2025 transaction?

Following the reported transaction, Merline Saintil directly owns 77,413 shares of Symbotic Inc. (SYM) Class A Common Stock.

Was SYM Director Saintil's stock sale part of a 10b5-1 trading plan?

Yes, the transaction was executed pursuant to a Rule 10b5-1 trading plan that Merline Saintil entered into on February 25, 2025.

What is Merline Saintil's role at SYM?

Merline Saintil serves as a Director on Symbotic Inc.'s (SYM) board, as indicated by the 'X' marked under the Director relationship field in the Form 4 filing.